METTL3 and head and neck squamous cell carcinoma: Due to the knowledge gap concerning METTL3’s impact on cisplatin response in HNSCC cells, we performed functional knockdown studies on an in vitro model and analyzed cell cycle distribution, apoptosis, expression of stem cell markers and the cells’ ability to colony formation after cisplatin treatment.